Product Details for: Ryzodeg 70/30
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
210UNITS/3ML (70UNITS/ML); 90UNIT/3ML (30UNITS/ML)
Autoinjector
351(a)
Ryzodeg 70/30
Disc
Proper Name
insulin degludec and insulin aspart
insulin degludec and insulin aspart
BLA Number
203313
203313
Applicant
Novo Nordisk Inc.
Novo Nordisk Inc.
Original Approval Date
September 25, 2015
September 25, 2015
Date of First Licensure